Factores etiopatogénicos de las enfermedades autoinmunes en el siglo XXI
MG Costa, AAP González - Revista Cubana de Investigaciones …, 2021 - medigraphic.com
Introducción: La etiología de las enfermedades autoinmunes aún se desconoce, aunque se
plantean diferentes causas. Objetivo: Describir el rol de factores como las hormonas …
plantean diferentes causas. Objetivo: Describir el rol de factores como las hormonas …
Approaches for controlling antibody-mediated allograft rejection through targeting B cells
Y Matsuda, T Watanabe, XK Li - Frontiers in Immunology, 2021 - frontiersin.org
Both acute and chronic antibody-mediated allograft rejection (AMR), which are directly
mediated by B cells, remain difficult to treat. Long-lived plasma cells (LLPCs) in bone …
mediated by B cells, remain difficult to treat. Long-lived plasma cells (LLPCs) in bone …
Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
Z Zhang, N Zhang, J Shi, C Dai, S Wu, M Jiao… - Frontiers in …, 2021 - frontiersin.org
The role of IL-33/ST2 signaling in cardiac allograft vasculopathy (CAV) is not fully
addressed. Here, we investigated the role of IL-33/ST2 signaling in allograft or recipient in …
addressed. Here, we investigated the role of IL-33/ST2 signaling in allograft or recipient in …
Ablation of BATF Alleviates Transplant Rejection via Abrogating the Effector Differentiation and Memory Responses of CD8+ T Cells
Allogeneic CD8+ T cells are prominently involved in allograft rejection, but how their effector
differentiation and function are regulated at a transcriptional level is not fully understood …
differentiation and function are regulated at a transcriptional level is not fully understood …
Interleukin-37 contributes to endometrial regenerative cell–mediated immunotherapeutic effect on chronic allograft vasculopathy
Y Qin, B Shao, S Ren, K Ye, H Qin, C Sun, Y Zhu… - Cytotherapy, 2024 - Elsevier
Background aims Chronic allograft vasculopathy (CAV) remains a predominant contributor
to late allograft failure after organ transplantation. Several factors have already been shown …
to late allograft failure after organ transplantation. Several factors have already been shown …
Transplantation immune responses: Biology, challenges, and opportunities using biomaterials
The organs or cells transplantation is well-established in clinics. However, despite the
increasing success rates and the broadening of various transplantation techniques, a key …
increasing success rates and the broadening of various transplantation techniques, a key …
New aspects of the influence of immunity and microbiome on heart transplant rejection
AS Golovkin, IV Kudryavtsev… - Russian Journal of …, 2022 - russjcardiol.elpub.ru
Currently, heart transplantation is the key treatment for patients with end-stage heart failure.
At the same time, the immunopathogenesis of chronic allograft rejection, which is a key …
At the same time, the immunopathogenesis of chronic allograft rejection, which is a key …
Mechanisms of Cardiac Allograft Rejection in Hyperlipidemic Recipients
L Williams - 2021 - search.proquest.com
Heart transplant is the only cure for end stage heart failure. It is a commonly performed
lifesaving operation in the United States, with over 3,000 heart transplants performed in …
lifesaving operation in the United States, with over 3,000 heart transplants performed in …
Etiopathogenic factors of autoimmune diseases in the 21st century
MG Costa, AAP González - Revista Cubana de Investigaciones …, 2021 - medigraphic.com
Introduction: The etiology of autoimmune diseases is still unknown, though several causes
have been suggested. Objective: Describe the role of hormones, eating, stress, infectious …
have been suggested. Objective: Describe the role of hormones, eating, stress, infectious …